Public Consultation

The National Blood Authority (NBA) periodically undertakes public consultations. The NBA welcomes comments from individuals or groups on topics in the required formats and timeframes.

Imported Plasma and Recombinant Product – Supply Contracts

Submissions Close 10.00am Wednesday 22 July 2015

Under the national blood arrangements administered by the National Blood Authority (NBA), Australia imports a range of plasma derived and recombinant products, to supplement domestic supply and obtain products that are not manufactured in Australia.

Contracts for a number of imported plasma and recombinant products expire on 30 June 2016.  The NBA is conducting a Request for Information and Stakeholder Consultation to decide whether to go to tender, negotiate outside the tendering arrangement or to undertake a combination of these actions.

The NBA is interested in seeking feedback from all stakeholders, including clinicians, nurses scientists and  suppliers to achieve the best possible outcome from the tender process. 

To view outcomes from previous consultations visit Closed Public Consultations.